blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1275396

EP1275396 - Use of angiotensin II fragments and analogs thereof in tissue repair [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.02.2015
Database last updated on 03.09.2024
Most recent event   Tooltip09.10.2015Lapse of the patent in a contracting state
New state(s): IE		published on 11.11.2015  [2015/46]
Applicant(s)For all designated states
UNIVERSITY OF SOUTHERN CALIFORNIA
University Park Campus
Los Angeles, CA 90089 / US
[2003/03]
Inventor(s)01 / Rodgers, Kathleen
Univ. of Southern California
Univ. Park Campus
Los Angeles, CA 90089 / US
02 / Dizerega, Gere Stodder
4491 Greenbrier Place, San Luis Obispo
San Luis Obispo, CA 93401 / US
 [2014/14]
Former [2003/16]01 / Rodgers, Kathleen
Univ. of Southern California, Univ. Park Campus
Los Angeles, CA 90089 / US
02 / Dizerega, Gere Stodder
4491 Greenbrier Place, San Luis Obispo
San Luis Obispo, CA 93401 / US
Former [2003/03]01 / Rodgers, Kathleen
Univ. of Southern California, Univ. Park Campus
Los Angeles, CA 90089 / US
02 / Dizerega, Gere Stodder
Univ. of Southern California, Univ. Park Campus
Los Angeles, CA 90089 / US
Representative(s)Pronovem
Office Van Malderen
Avenue Josse Goffin 158
1082 Bruxelles / BE
[2014/14]
Former [2008/30]pronovem
Office Van Malderen Avenue Josse Goffin 158
1082 Bruxelles / BE
Former [2006/49]pronovem
Office Van Malderen Ave. Josse Goffin 158
1082 Brussels / BE
Former [2003/03]Vandersteen, Pieter, et al
Office Van Malderen, Place Reine Fabiola, 6/1
1083 Bruxelles / BE
Application number, filing date02078361.914.11.1995
[2003/03]
Priority number, dateUS1994033778114.11.1994         Original published format: US 337781
US1995046577506.06.1995         Original published format: US 465775
[2003/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1275396
Date:15.01.2003
Language:EN
[2003/03]
Type: A3 Search report 
No.:EP1275396
Date:07.01.2004
[2004/02]
Type: B1 Patent specification 
No.:EP1275396
Date:02.04.2014
Language:EN
[2014/14]
Search report(s)(Supplementary) European search report - dispatched on:EP20.11.2003
ClassificationIPC:A61K38/08, A61P17/02
[2003/03]
CPC:
C07K7/14 (EP,US); A61K38/085 (EP,US); A61P17/02 (EP);
A61P43/00 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2003/03]
TitleGerman:Verwendung von Angiotensin II Fragmenten und deren Analogen für Gewebewiederherstellung[2013/45]
English:Use of angiotensin II fragments and analogs thereof in tissue repair[2003/03]
French:Utilisation de fragments d'angiotensine II et d'analogues de celle-ci pour la réparation des tissus[2003/03]
Former [2003/03]Verwendung von Angiotensin II Fragmenten und deren Analogen fÜr Gewebewiederherstellung
Examination procedure10.09.2002Examination requested  [2003/03]
22.02.2008Despatch of a communication from the examining division (Time limit: M06)
20.08.2008Reply to a communication from the examining division
02.02.2010Despatch of a communication from the examining division (Time limit: M04)
10.06.2010Reply to a communication from the examining division
26.09.2011Despatch of a communication from the examining division (Time limit: M06)
26.01.2012Reply to a communication from the examining division
24.10.2013Communication of intention to grant the patent
20.02.2014Fee for grant paid
20.02.2014Fee for publishing/printing paid
Parent application(s)   TooltipEP95942418.5  / EP0792158
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19950942418) is  09.05.2000
Opposition(s)06.01.2015No opposition filed within time limit [2015/11]
Fees paidRenewal fee
10.09.2002Renewal fee patent year 03
10.09.2002Renewal fee patent year 04
10.09.2002Renewal fee patent year 05
10.09.2002Renewal fee patent year 06
10.09.2002Renewal fee patent year 07
10.09.2002Renewal fee patent year 08
06.05.2004Renewal fee patent year 09
22.11.2004Renewal fee patent year 10
29.11.2005Renewal fee patent year 11
29.01.2007Renewal fee patent year 12
27.11.2007Renewal fee patent year 13
25.11.2008Renewal fee patent year 14
25.11.2009Renewal fee patent year 15
24.11.2010Renewal fee patent year 16
23.11.2011Renewal fee patent year 17
26.11.2012Renewal fee patent year 18
27.11.2013Renewal fee patent year 19
Penalty fee
Additional fee for renewal fee
30.11.200309   M06   Fee paid on   06.05.2004
30.11.200612   M06   Fee paid on   29.01.2007
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT02.04.2014
BE02.04.2014
DK02.04.2014
ES02.04.2014
IT02.04.2014
MC02.04.2014
NL02.04.2014
SE02.04.2014
GR03.07.2014
PT04.08.2014
IE14.11.2014
LU14.11.2014
CH30.11.2014
LI30.11.2014
[2015/46]
Former [2015/33]AT02.04.2014
BE02.04.2014
DK02.04.2014
ES02.04.2014
IT02.04.2014
MC02.04.2014
NL02.04.2014
SE02.04.2014
GR03.07.2014
PT04.08.2014
LU14.11.2014
CH30.11.2014
LI30.11.2014
Former [2015/32]AT02.04.2014
BE02.04.2014
DK02.04.2014
ES02.04.2014
IT02.04.2014
MC02.04.2014
NL02.04.2014
SE02.04.2014
GR03.07.2014
PT04.08.2014
LU14.11.2014
Former [2015/30]AT02.04.2014
BE02.04.2014
DK02.04.2014
ES02.04.2014
IT02.04.2014
NL02.04.2014
SE02.04.2014
GR03.07.2014
PT04.08.2014
LU14.11.2014
Former [2015/18]AT02.04.2014
BE02.04.2014
DK02.04.2014
ES02.04.2014
IT02.04.2014
NL02.04.2014
SE02.04.2014
GR03.07.2014
PT04.08.2014
Former [2015/08]AT02.04.2014
BE02.04.2014
DK02.04.2014
ES02.04.2014
NL02.04.2014
SE02.04.2014
GR03.07.2014
PT04.08.2014
Former [2015/02]AT02.04.2014
ES02.04.2014
NL02.04.2014
SE02.04.2014
GR03.07.2014
PT04.08.2014
Former [2014/51]AT02.04.2014
ES02.04.2014
NL02.04.2014
SE02.04.2014
GR03.07.2014
Former [2014/50]ES02.04.2014
NL02.04.2014
SE02.04.2014
GR03.07.2014
Documents cited:Search[DX]US5015629  (DIZEREGA GERE S [US]) [DX] 1,21-24 * column W *;
 [PX]WO9508337  (UNIV SOUTHERN CALIFORNIA [US]) [PX] 1-24 * the whole document *;
 [PX]WO9508565  (UNIV SOUTHERN CALIFORNIA [US]) [PX] 1-24 * the whole document *
by applicantWO9508337
 WO9508565
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.